Prevalence of Mpox vaccine acceptance and hesitancy among people living with HIV: a comprehensive systematic review and meta-analysis
AIDS Research and Therapy,
Год журнала:
2025,
Номер
22(1)
Опубликована: Март 8, 2025
Vaccine
acceptance
among
People
Living
with
HIV
(PLWH)
is
crucial
for
managing
and
mitigating
the
spread
of
infectious
diseases,
including
Mpox.
This
systematic
review
meta-analysis
assess
rate
vaccine
Mpox
PLWH
identify
factors
influencing
these
rates.
We
searched
major
databases
PubMed,
Embase,
Web
Science
up
to
30
August
2024
observational
studies
involving
that
reported
on
mpox
A
random-effects
model
was
employed
meta-analysis,
utilizing
R
software
version
4.4.
Heterogeneity
quantified
using
I²
statistic,
methodological
quality
each
study
assessed
a
modified
Newcastle-Ottawa
Scale.
Out
1,123
articles
identified,
17
met
inclusion
criteria
included
7,248
participants.
The
pooled
estimate
61.1%
(95%
CI:
44.2-75.7%),
high
heterogeneity
(I²
=
99%).
Additionally,
hesitancy
prevalence
13.2%,
2.4-48.6%),
reflecting
substantial
variability
had
98%).
reveal
moderate
considerable
PLWH.
To
further
increase
uptake
address
any
remaining
in
this
at-risk
population,
targeted
public
health
strategies
ongoing
research
are
necessary.
Strengthening
critical
safeguarding
against
emerging
diseases
such
as
Not
applicable.
Язык: Английский
The Mpox Response Among Key Populations at High Risk of or Living with HIV in Rwanda: Leveraging the Successful National HIV Control Program for More Impactful Interventions
Vaccines,
Год журнала:
2025,
Номер
13(3), С. 307 - 307
Опубликована: Март 13, 2025
Mpox,
an
emerging
zoonotic
infectious
disease,
presents
a
significant
public
health
threat,
especially
among
high-risk
groups
like
female
sex
workers
and
men
who
have
with
men.
This
commentary
reviews
summarizes
Rwanda’s
response
to
mpox,
focusing
on
its
intersection
HIV.
Rwanda
has
adopted
integrated
strategy
tackle
both
mpox
HIV
by
leveraging
lessons
experience
from
the
country’s
success
in
management
of
COVID-19,
enhancing
community
engagement
outcomes.
To
ensure
long-term
resilience,
must
continue
invest
surveillance
research,
expand
vaccination
efforts,
address
stigma,
foster
regional
impactful
partnerships.
Investing
fostering
scientific
operational
research
will
generate
invaluable
evidence
that
could
lead
implementation
evidence-based
policymaking
cost-effective
interventions.
Язык: Английский
Mpox Vaccine Hesitancy Among Brazilian Men Who Have Sex with Men: A National Cross-Sectional Study
Vaccines,
Год журнала:
2024,
Номер
12(11), С. 1229 - 1229
Опубликована: Окт. 29, 2024
Background:
Mpox
is
a
viral
zoonosis
that
has
gained
increased
attention
due
to
global
outbreak
in
2022,
significantly
impacting
men
who
have
sex
with
(MSM).
Vaccination
for
this
disease
poses
public
health
challenge;
because
it
carries
strong
stigma,
there
may
be
greater
hesitancy
vulnerable
groups.
Objectives:
This
study
aimed
determine
the
prevalence
and
factors
associated
vaccine
among
Brazilian
MSM.
Methods:
A
cross-sectional
was
conducted
between
September
December
2022
using
an
online
survey
targeted
at
Recruitment
carried
out
through
social
media
dating
apps.
The
sample
consisted
of
1449
participants
analysis
involved
bivariate
logistic
regression.
Results:
7.57%.
significant
were
primarily
related
sexual
practices
attitudes
towards
exposure
diagnosis,
such
as
not
“glory
holes”
(aOR:
19.82;
95%
CI:
1.60–245.69),
reluctance
undergo
pre-
post-exposure
testing
9.54;
5.52–16.48),
knowing
close
contacts
diagnosed
4.09;
1.72–9.73).
Participants
would
take
precautions
after
diagnosis
3.00;
1.27–7.07)
those
disclose
their
serological
status
1.93;
1.13–3.30)
also
showed
higher
likelihood
hesitancy.
Conclusion:
Public
strategies
should
address
these
expand
knowledge
about
vaccination
barriers,
plan
educational
campaigns
messaging
MSM
population,
provide
inclusive
healthcare
environments
increase
acceptance
reduce
transmission
Язык: Английский